HomeLIMN • NASDAQ
add
Liminatus Pharma Inc
Previous close
$4.56
Day range
$5.00 - $5.46
Year range
$4.56 - $16.43
Market cap
135.28M USD
Avg Volume
32.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 167.00K | -78.08% |
Net income | -229.00K | 70.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.00K | -21.50% |
Total assets | 5.41M | 141.26% |
Total liabilities | 24.75M | 37.22% |
Total equity | -19.34M | — |
Shares outstanding | 112.22M | — |
Price to book | -26.82 | — |
Return on assets | -44.33% | — |
Return on capital | 10.67% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -229.00K | 70.30% |
Cash from operations | -141.00K | 55.80% |
Cash from investing | -550.00K | -17.27% |
Cash from financing | 700.00K | -41.67% |
Net change in cash | 9.00K | 104.96% |
Free cash flow | -507.49K | -3.21% |
About
Founded
2020
Headquarters
Website
